Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 19/20 | 0.55 |
| ▸ | F2R | P25116 | 7/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538574 | 0.93 | ITGB3 (0.51) | ITGB3ITGA2BF2R | |
| SCHEMBL7498839 | 0.91 | KDM4E (0.51) | ITGB3ITGA2BF2RKDM4EPKM | |
| SCHEMBL7440100 | 0.89 | ITGB3 (0.57) | ITGB3ITGA2BF2RKDM4EPKM | |
| SCHEMBL7500568 | 0.88 | ITGB3 (0.57) | ITGB3ITGA2BF2R | |
| SCHEMBL7503854 | 0.87 | ITGB3 (0.53) | ITGB3ITGA2BF2R | |
| SCHEMBL6937902 | 0.87 | ITGB3 (0.57) | ITGB3ITGA2BF2R | |
| SCHEMBL6938379 | 0.87 | ITGB3 (0.57) | ITGB3ITGA2BF2R | |
| SCHEMBL6936431 | 0.87 | ITGB3 (0.57) | ITGB3ITGA2BF2R | |
| SCHEMBL6939721 | 0.87 | ITGB3 (0.57) | ITGB3ITGA2BF2R | |
| SCHEMBL7839625 | 0.87 | ITGB3 (0.74) | ITGB3ITGA2BF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0669912-B1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-12-05 | — | — | EP | disclosed |
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |